Navigation Links
Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates
Date:2/4/2008

While Chantix and Cialis Lead, Many Heavily Advertised Brands Lag Behind

NEW YORK, Feb. 4 /PRNewswire/ -- Manhattan Research, a leader in syndicated research and marketing services for the health and pharmaceutical industry, today revealed the top pharmaceutical branded product websites ranked by offline requests by U.S. adult consumers. The product site rankings are based on the comprehensive online consumer research study with 5,112 U.S. adults titled ePharma Consumer(R) v7.0: The Future of Integrated DTC Marketing. In addition to the top product site rankings, the study provides in-depth data on more than 200 leading pharmaceutical product sites including site satisfaction, site search rationales, tools and features desired on product sites, and a wide range of consumer actions taken afterwards.

"Having the most unique visitors is no longer the ultimate goal of a successful pharmaceutical product site," says Mark Bard, president of Manhattan Research. He continues, "Brand teams and agencies are being challenged to demonstrate the economic and strategic value created by these online destinations - beyond the raw number of visitors or page views. After all, if a site is all traffic and no action then what is the strategic value of the site?"

Top 10 Pharmaceutical Branded Websites Driving Prescription Drug Requests

1. Chantix

2. Cialis

3. Viagra

4. Aciphex

5. Ambien CR

6. Levitra

7. Lamisil

8. Lunesta

9. Wellbutrin XL

10. Ortho Evra

Source: ePharma Consumer(R) v7.0, Manhattan Research, LLC

To learn more about consumer segments of pharmaceutical information seekers, contact Manhattan Research by visiting http://www.manhattanresearch.com/ePC.htm or by emailing sales@manhattanresearch.com.

Some of the additional product sites researched within ePharma Consumer(R) v7.0 include the following: Abilify, Actonel, Advair, Aranesp, Aricept, Avandia, Boniva, Botox, Caduet, Concerta, Crestor, Cymbalta, Depakote, Depo- Provera, Detrol LA, Effexor XR, Enbrel, Flomax, Flonase, Flovent, Fosamax, Gardasil, Glucophage XR, Humira, Humulin, Imitrex, Lantus, Lexapro, Lipitor, Nasacort, Nasonex, Neulasta, Neurontin, Nexium, Norvasc, NuvaRing, Ortho Tri- Cyclen Lo, Paxil, Plavix, Pravachol, Prevacid, Protonix, Provigil, Pulmicort, Restasis, Risperdal, Rozerem, Seasonale, Seroquel, Singulair, Strattera, Tamiflu, Topamax, Toprol XL, Tricor, Valtrex, Vytorin, Yasmin, Yaz, Zocor, Zoloft, Zomig, Zyprexa and Zyrtec.

Please visit http://www.manhattanresearch.com/ePC.htm to download the ePharma Consumer(R) product brochure, request subscription information, and to listen to two audio presentations summarizing highlights from the research.

Manhattan Research

ePharma Consumer(R) v7.0 is a syndicated multi-client study and advisory service focused on key research topics and trends impacting online U.S. consumers seeking pharmaceutical information. The study was fielded in December 2007 among 5,112 U.S. adult consumers. In addition to ePharma Consumer(R), Manhattan Research conducts five additional research studies annually among consumers and physicians in the United States and in Europe: Cybercitizen(R) Health US, Cybercitizen(R) Health Europe, Taking the Pulse(R) US, Taking the Pulse(R) Europe, and ePharma Physician(R). Each study serves a unique purpose and focuses on specific aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analyses among more than 50 consumer therapeutic segments and 25 physician specialist segments.

Contact:

Erica Alexander Martini

212-255-7799

Ealexander@Manhattanresearch.Com


'/>"/>
SOURCE Manhattan Research
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
5. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
6. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
7. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
8. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands ... list which highlights outstanding performance by individuals under 30 years of age. The Forbes ... fields from Sports and Entertainment to Venture Capital and Science. , In 2017, ...
(Date:11/15/2018)... ... November 14, 2018 , ... ... world’s first self-learning snore-reduction mask to the public. It is estimated that ... of sleep for themselves and their partner. The resulting daytime fatigue causes extreme ...
(Date:11/13/2018)... ... November 12, 2018 , ... ... contamination that two large U.S. studies, published last week, confirm pose a significant ... of Infection Control (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. ...
(Date:11/13/2018)... BOSTON (PRWEB) , ... November 13, 2018 , ... ... an analysis of the spine technology market last week that asserts it is ... global patient population. , Humad’s analysis describes market consolidation, pricing pressure ...
Breaking Biology Technology:
(Date:11/23/2018)... ... November 23, 2018 , ... uBiome, the leader ... of the G. Oppenheimer Center for Neurobiology of Stress and Resilience, to its ... the world, Dr. Mayer will bring to uBiome his expertise on the connections ...
(Date:11/20/2018)... ... November 19, 2018 , ... SF Bay ... -- the first and only non-invasive buttock lift procedure, with no injections necessary! ... strengthen, tone and firm the buttocks to provide a safe and completely non-invasive ...
(Date:11/20/2018)... ... , ... Like many large breed dogs, Jack, a Great Pyrenees, began showing ... his mom, Rebecca, noticed he was slow to get up and knew something was ... were confirmed: Jack had bilateral hip dysplasia, a congenital condition affecting the formation of ...
Breaking Biology News(10 mins):